Stay updated on Glycine Supplement for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Glycine Supplement for Severe COVID-19 Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has removed a citation regarding the clinical features of patients infected with the 2019 novel coronavirus in Wuhan, China, which is a significant loss of core content.
    Difference
    0.2%
    Check dated 2025-05-08T13:07:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:49:13.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed information about a clinical trial studying glycine as a treatment for severe COVID-19, while retaining the trial's basic structure and location. The revision number has also been updated.
    Difference
    16%
    Check dated 2025-04-16T14:44:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T10:08:38.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:38:31.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T21:54:51.000Z thumbnail image

Stay in the know with updates to Glycine Supplement for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.